Novavax (NVAX) - Revenue

Revenue in 2024 (TTM): NZ$1.37 Billion

According to Novavax's latest financial reports the company's current revenue (TTM

) is NZ$1.47 Billion. In 2023 the company made a revenue of NZ$1.09 Billion a decrease over the revenue in the year 2022 that were of NZ$2.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novavax from 1996 to 2024

Annual revenue

Year	Revenue	Change
2024 (TTM)	NZ$1.37 B	25.22%
2023	NZ$1.09 B	-50.03%
2022	NZ$2.19 B	30.77%
2021	NZ$1.67 B	154.61%
2020	NZ$0.65 B	2278.73%
2019	NZ$27.7 M	-45.79%
2018	NZ$51.11 M	16.45%
2017	NZ$43.89 M	98.05%
2016	NZ$22.16 M	-58.15%
2015	NZ$52.96 M	35.36%
2014	NZ$39.13 M	53.75%
2013	NZ$25.45 M	-5.16%
2012	NZ$26.83 M	42.59%
2011	NZ$18.81 M	4132.99%
2010	NZ$0.44 M	-0.64%
2009	NZ$0.44 M	-75.6%
2008	NZ$1.83 M	7.62%
2007	NZ$1.7 M	-74.37%
2006	NZ$6.64 M	-38.5%
2005	NZ$10.8 M	-13.57%
2004	NZ$12.5 M	-31.02%
2003	NZ$18.13 M	-33.2%
2002	NZ$27.14 M	-53.17%
2001	NZ$57.95 M	937.7%
2000	NZ$5.58 M	143.23%
1999	NZ$2.29 M	72.87%
1998	NZ$1.32 M	28.47%
1997	NZ$1.03 M	143.49%
1996	NZ$0.42 M

Revenue for similar companies or competitors

Company	Revenue	Revenue differencediff.	Country
Agenus AGEN	NZ$0.28 B	-81.06%	🇺🇸 USA
Sarepta Therapeutics SRPT	NZ$2.86 B	93.61%	🇺🇸 USA
Emergent BioSolutions EBS	NZ$1.91 B	29.15%	🇺🇸 USA
BioCryst Pharmaceuticals BCRX	NZ$0.72 B	-51.30%	🇺🇸 USA
AstraZeneca AZN	NZ$94.45 B	6,282.18%	🇬🇧 UK
Pfizer PFE	NZ$105.00 B	6,994.84%	🇺🇸 USA
Novartis NVS	NZ$90.34 B	6,004.69%	🇨🇭 Switzerland
NanoViricides NNVC	N/A	N/A	🇺🇸 USA
GlaxoSmithKline GSK	NZ$70.31 B	4,650.98%	🇬🇧 UK
Celldex Therapeutics CLDX	NZ$17.42 M	-98.82%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Revenue for Novavax (NVAX)

Revenue in 2024 (TTM): NZ$1.37 Billion